Metropolis Healthcare Q4 Results: Profit dips 19% to Rs 29 crore

Metropolis Healthcare connected Tuesday said its consolidated nett net declined 19 per cent to Rs 29 crore successful the 4th quarter ended March 4th 2025. The diagnostics concatenation had reported a nett net of Rs 36 crore for the January-March play of FY24.

Revenue from operations roseate to Rs 345 crore successful the play nether reappraisal from Rs 331 crore successful the year-ago period, Metropolis Healthcare said successful a regulatory filing.

For FY25, the institution reported a nett net of Rs 146 crore arsenic compared with Rs 128 crore successful 2023-24.

The institution said its committee has approved the re-appointment of Ameera Shah arsenic Chairperson and Whole-time Director of the institution for 5 years with effect from March 18, 2026.

The committee besides appointed Surendran Chemmenkotil, presently serving arsenic CEO, arsenic Managing Director for 3 years with effect from June 1, 2025.

Shares of Metropolis connected Tuesday ended 0.66 per cent down astatine Rs 1,701.85 apiece connected BSE.